Enterprise partnerships Qured has established and ongoing partnerships with large organisations and benefits platforms (e.g., Epassi UK, American Airlines, British Airways, Gophr), indicating receptiveness to B2B collaborations and corporate wellness programs. This presents a clear path for targeted outreach to similar employers and travel/aviation sectors seeking preventive health benefits.

Workforce health impact The program claims to reduce workforce sickness absence by up to 20% and high adoption within one month among employees. This strengthens the value proposition for HR and operations leaders focused on productivity, safety-critical industries, and reducing downtime through preventive screenings.

Data integration potential Recent news shows partnerships combining genomic and blood diagnostics in a single experience, suggesting an opportunity to offer integrated health insights to enterprise clients, enabling more personalized employee health journeys and deeper engagement.

Lean scalability Operating with 11-50 employees and a cloud-based tech stack (AWS, Vercel, GTM, etc.), Qured appears capable of scaling partnerships without heavy on-premises infrastructure. This makes it attractive for mid-market companies seeking scalable wellness solutions with minimal IT burden.

Revenue expansion potential Current revenue is modest but has attracted $5.9M in funding and a growing list of corporate clients; there is opportunity to upsell broader screening panels, longitudinal health programs, and data-driven wellness analytics to enterprise buyers and benefits platforms.